Mitral homograft in tricuspid position: indications for implantation and surgical technique

Author:

Komarov Roman N.1ORCID,Nuzhdin Mikhail D.2ORCID,Belov Vyacheslav A.3ORCID,Chernyavsky Stanislav V.4ORCID,Ismailbayev Alisher M.1ORCID,Drakina Olga V.1ORCID,Tsaregorodtsev Anton V.4ORCID,Baziyants Lusine R.1ORCID

Affiliation:

1. Federal State Autonomous Educational Institution of Higher Education “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health of the Russian Federation (Sechenov University)

2. State Budgetary Institution of Health Care “Chelyabinsk Regional Clinical Hospital”

3. Federal State Budgetary Institution “Federal Center for High Medical Technologies” of Healthcare Ministry of the Russian Federation

4. Federal State Autonomous Educational Institution of Higher Education “Pirogov Russian National Research Medical University”

Abstract

HighlightsThe article presents the latest data on the techniques of implantation of the mitral homograft in the tricuspid position, and identifies groups of patients who are best suited for this method. Moreover, the article describes the evolution of this type of replacement, and highlights that many surgical techniques, although justified, require further study to show demonstrate their advantages. AbstractDespite the general trend in cardiac surgery towards valve-preserving interventions, valve replacements remain relevant, and the search for the perfect prosthetic valve continues. Many believe that tricuspid valve replacement using a mitral homograft can be the method of choice in certain situations. The analysis of the studies found in the PubMed database led the authors to the following conclusions: most of the data on the use of this technique in patients with infective endocarditis (IE), other indications are congenital heart disease (CHD) and rheumatic heart disease. Patients with IE who have undergone tricuspid valve replacement using a mitral homograft have good medium-term prospects, and respond well to medical treatment of recurrent IE. The mitral homograft in the tricuspid position remains intact even after prosthetic endocarditis. In this regard, it is possible to perform reconstructive intervention in case of prosthetic valve dysfunction without the need for repeated replacement. Such interventions are relevant for patients with growing heart for whom annuloplasty at the first stage of surgery is undesirable. Moreover, it is also cost-effective due to the high cost and low availability of homografts. The possibility of repeated tricuspid valve-in-valve replacement is important for patients who may not survive open surgery. To date, there are not enough long-term and short-term data on using a mitral homograft for tricuspid valve replacement, however, it can be assumed that the results of this technique will be positive provided that the appropriate implantation technique and strict patient selection are ensured. Many authors have come to the conclusion that the optimal homograft implantation technique includes sewing of the graft`s papillary muscles into the wall of the myocardium of the right ventricle (RV), fixating them on the outer surface of the RV, anatomical positioning of the homograft (anterior leaflet faces towards the IVS), and the use of an annuloplasty ring.

Publisher

NII KPSSZ

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Rehabilitation,Emergency Medicine,Surgery

Reference21 articles.

1. Arbulu A., Holmes R.J., Asfaw I. Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience. J Heart Valve Dis. 1993 Mar;2(2):129-37; discussion 138-9. PMID: 8261149.

2. Mestres C.A., Miro J.M., Pare J.C., Pomar J.L. Six-year experience with cryopreserved mitral homografts in the treatment of tricuspid valve endocarditis in HIV-infected drug addicts. J Heart Valve Dis. 1999 Sep;8(5):575-7.

3. Pomar, José Luís and Carlos – A. Mestres. “Role of Atrioventricular Homograft Valves in Atrioventricular Valve Replacement.” Asian Cardiovascular and Thoracic Annals 4 (1996): 122 - 125.

4. Pomar JL, Mestres CA, Pare JC, Miro JM. Management of persistent tricuspid endocarditis with transplantation of cryopreserved mitral homografts. J Thorac Cardiovasc Surg. 1994 Jun;107(6):1460-3. PMID: 8196388.

5. Ramsheyi A, D'Attellis N, Le Lostec Z, Fegueux S, Acar C. Partial mitral homograft for tricuspid valve repair. Ann Thorac Surg. 1997 Nov;64(5):1486-8. doi: 10.1016/S0003-4975(97)00944-2. PMID: 9386736.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Prosthetics of heart valves: current trends;Journal of Volgograd State Medical University;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3